The quality of primary care provided to the elderly in Israel

Podell, Rachel; Kaufman-Shriqui, Vered; Sagy, Yael Wolff; Manor, Orly; Ben-Yehuda, Arie

doi:10.1186/s13584-018-0214-3

Israel Journal of Health Policy Research

Table 3 Quality indicator performance rates stratified by gender and socioeconomic position, 2015

From: The quality of primary care provided to the elderly in Israel

Influenza vaccination
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	45,214	70,197	64.41%	54,684	94,383	57.94%	99,898	164,580	60.70%
	75–84	35,469	50,525	70.20%	47,185	75,635	62.39%	82,654	126,160	65.52%
	85 or above	12,234	16,742	73.07%	21,008	32,913	63.83%	33,242	49,655	66.95%
	total	92,917	137,464	67.59%	122,877	202,931	60.55%	215,794	340,395	63.40%
Middle & high SEP	65–74	93,556	156,522	59.77%	97,471	167,895	58.05%	191,027	324,417	58.88%
	75–84	50,355	69,352	72.61%	59,586	87,697	67.95%	109,941	157,049	70.00%
	85 or above	16,090	22,154	72.63%	23,503	35,656	65.92%	39,593	57,810	68.49%
	total	160,001	248,028	64.51%	180,560	291,248	62.00%	340,561	539,276	63.15%
Total		252,918	385,492	65.61%	303,437	494,179	61.40%	556,355	879,671	63.25%
Pneumococcal vaccination
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	49,631	59,066	84.03%	60,870	77,072	78.98%	110,501	136,138	81.17%
	75–84	NA	NA	NA	NA	NA	NA	NA	NA	NA
	85 or above	NA	NA	NA	NA	NA	NA	NA	NA	NA
	total	49,631	59,066	84.03%	60,870	77,072	78.98%	110,501	136,138	81.17%
Middle & high SEP	65–74	164,901	208,638	79.04%	181,131	240,636	75.27%	346,032	449,274	77.02%
	75–84	NA	NA	NA	NA	NA	NA	NA	NA	NA
	85 or above	NA	NA	NA	NA	NA	NA	NA	NA	NA
	total	164,901	208,638	79.04%	181,131	240,636	75.27%	346,032	449,274	77.02%
Total		214,532	267,704	80.14%	242,001	317,708	76.17%	456,533	585,412	77.98%
Benzodiazepine overuse
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	2698	70,197	3.84%	4350	94,383	4.61%	7048	164,580	4.28%
	75–84	3435	50,525	6.80%	6775	75,635	8.96%	10,210	126,160	8.09%
	85 or above	2021	16,742	12.07%	4562	32,913	13.86%	6583	49,655	13.26%
	total	8154	137,464	5.93%	15,687	202,931	7.73%	23,841	340,395	7.00%
Middle & high SEP	65–74	2639	156,522	1.69%	4880	167,895	2.91%	7519	324,417	2.32%
	75–84	2888	69,352	4.16%	5848	87,697	6.67%	8736	157,049	5.56%
	85 or above	1721	22,154	7.77%	4041	35,656	11.33%	5762	57,810	9.97%
	total	7248	248,028	2.92%	14,769	291,248	5.07%	22,017	539,276	4.08%
Total		15,402	385,492	4.00%	30,456	494,179	6.16%	45,858	879,671	5.21%
Long-term benzodiazepine
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	1675	70,197	2.39%	2567	94,383	2.72%	4242	164,580	2.58%
	75–84	1180	50,525	2.34%	2297	75,635	3.04%	3477	126,160	2.76%
	85 or above	424	16,742	2.53%	896	32,913	2.72%	1320	49,655	2.66%
	total	3279	137,464	2.39%	5760	202,931	2.84%	9039	340,395	2.66%
Middle & high SEP	65–74	2544	156,522	1.63%	4163	167,895	2.48%	6707	324,417	2.07%
	75–84	1478	69,352	2.13%	2713	87,697	3.09%	4191	157,049	2.67%
	85 or above	500	22,154	2.26%	1032	35,656	2.89%	1532	57,810	2.65%
	total	4522	248,028	1.82%	7908	291,248	2.72%	12,430	539,276	2.30%
Total		7801	385,492	2.02%	13,668	494,179	2.77%	21,469	879,671	2.44%
BMI documentation
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	53,898	64,758	83.23%	70,201	85,632	81.98%	124,099	150,390	82.52%
	75–84	40,220	46,809	85.92%	57,509	69,604	82.62%	97,729	116,413	83.95%
	85 or above	NA	NA	NA	NA	NA	NA	NA	NA	NA
	total	94,118	111,567	84.36%	127,710	155,236	82.27%	221,828	266,803	83.14%
Middle & high SEP	65–74	125,290	160,318	78.15%	137,598	174,765	78.73%	262,888	335,083	78.45%
	75–84	61,741	74,009	83.42%	77,274	94,670	81.62%	139,015	168,679	82.41%
	85 or above	NA	NA	NA	NA	NA	NA	NA	NA	NA
	total	187,031	234,327	79.82%	214,872	269,435	79.75%	401,903	503,762	79.78%
Total		281,149	345,894	81.28%	342,582	424,671	80.67%	623,731	770,565	80.94%
Underweight
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	6122	53,898	11.36%	6816	70,201	9.71%	12,938	124,099	10.43%
	75–84	5127	40,220	12.75%	6426	57,509	11.17%	11,553	97,729	11.82%
	85 or above	2511	13,178	19.05%	4453	22,450	19.84%	6964	35,628	19.55%
	total	13,760	107,296	12.82%	17,695	150,160	11.78%	31,455	257,456	12.22%
Middle & high SEP	65–74	11,220	125,261	8.96%	19,388	137,576	14.09%	30,608	262,837	11.65%
	75–84	7874	62,120	12.68%	11,326	77,765	14.56%	19,200	139,885	13.73%
	85 or above	3683	17,688	20.82%	5686	25,961	21.90%	9369	43,649	21.46%
	total	22,777	205,069	11.11%	36,400	241,302	15.08%	59,177	446,371	13.26%
Total		36,537	312,365	11.70%	54,095	391,462	13.82%	90,632	703,827	12.88%
Weight loss
		Male			Female			Total
SEP	Age	Numerator	Denominator	Rate	Numerator	Denominator	Rate	Numerator	Denominator	Rate
Low SEP	65–74	2694	44,749	6.02%	3637	57,831	6.29%	6331	102,580	6.17%
	75–84	2417	36,760	6.58%	4038	52,070	7.75%	6455	88,830	7.27%
	85 or above	923	11,934	7.73%	1904	19,601	9.71%	2827	31,535	8.96%
	total	6034	93,443	6.46%	9579	129,502	7.40%	15,613	222,945	7.00%
Middle & high SEP	65–74	4128	103,165	4.00%	5706	114,904	4.97%	9834	218,069	4.51%
	75–84	3398	58,820	5.78%	5062	73,364	6.90%	8460	132,184	6.40%
	85 or above	1408	16,582	8.49%	2358	23,628	9.98%	3766	40,210	9.37%
	total	8934	178,567	5.00%	13,126	211,896	6.19%	22,060	390,463	5.65%
Total		14,968	272,010	5.50%	22,705	341,398	6.65%	37,673	613,408	6.14%

Back to article page

ISSN: 2045-4015

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com